Deciphera Pharmaceuticals Inc (DCPH)
25.46
+0.02
(+0.06%)
USD |
NASDAQ |
May 15, 15:20
Deciphera Pharmaceuticals Cash and Short Term Investments (Quarterly): 272.53M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 272.53M |
| December 31, 2023 | 306.22M |
| September 30, 2023 | 339.08M |
| June 30, 2023 | 328.74M |
| March 31, 2023 | 398.63M |
| December 31, 2022 | 324.49M |
| September 30, 2022 | 364.58M |
| June 30, 2022 | 383.85M |
| March 31, 2022 | 256.55M |
| December 31, 2021 | 285.63M |
| September 30, 2021 | 342.27M |
| June 30, 2021 | 395.35M |
| March 31, 2021 | 502.18M |
| December 31, 2020 | 551.93M |
| September 30, 2020 | 545.32M |
| Date | Value |
|---|---|
| June 30, 2020 | 610.34M |
| March 31, 2020 | 691.50M |
| December 31, 2019 | 579.58M |
| September 30, 2019 | 634.60M |
| June 30, 2019 | 225.42M |
| March 31, 2019 | 262.34M |
| December 31, 2018 | 293.76M |
| September 30, 2018 | 320.88M |
| June 30, 2018 | 346.53M |
| March 31, 2018 | 179.87M |
| December 31, 2017 | 196.75M |
| September 30, 2017 | 82.15M |
| June 30, 2017 | 93.99M |
| December 31, 2016 | 57.46M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
225.42M
Minimum
Jun 2019
691.50M
Maximum
Mar 2020
416.94M
Average
374.21M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 9.67B |
| Dynavax Technologies Corp | 723.54M |
| Gilead Sciences Inc | 4.718B |
| Esperion Therapeutics Inc | 226.61M |
| SINTX Technologies Inc | 3.34M |